Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/21/25 21:00 | 3/19/25 | ADMA | Health | BioPrd | Biological Products, (No Diag | Grossman Adam S | NJ | DO | P,CEO,,I | 4 | S.dm | -13,426 | 16.86 | 0 | -796 | 3,806 | D | |||||||||||||||
11/22/24 21:05 | 11/22/24 | ADMA | Health | BioPrd | Biological Products, (No Diag | Tade Brad L. | FL | O | CFO,Trea | 1 | S | -317 | 21.15 | 0 | -15 | 199 | D | |||||||||||||||
9/11/24 21:00 | 9/9/24 | ADMA | Health | BioPrd | Biological Products, (No Diag | Guiheen Lawrence P. | NJ | D | 1 | S.d | -166 | 18.47 | 0 | -9 | 155 | D | ||||||||||||||||
8/30/24 21:05 | 8/30/24 | ADMA | Health | BioPrd | Biological Products, (No Diag | Kestenberg-Messina Kaitlin M. | FL | O | COO,SVP, | 1 | S.d | -408 | 16.90 | 0 | -24 | 449 | D | |||||||||||||||
8/30/24 21:02 | 8/29/24 | ADMA | Health | BioPrd | Biological Products, (No Diag | Grossman Jerrold B | NJ | D | 1 | S.d | -2,364 | 17.27 | 0 | -137 | 560 | D | ||||||||||||||||
8/27/24 21:00 | 8/23/24 | ADMA | Health | BioPrd | Biological Products, (No Diag | Kwon Young | NJ | D | 1 | S | -1,096 | 18.26 | 0 | -60 | 241 | D | ||||||||||||||||
3/19/24 21:48 | 3/18/24 | ADMA | Health | BioPrd | Biological Products, (No Diag | Elms Steve | NY | D | 2 | S.m | -9,143 | 6.10 | 0 | -1,500 | 2,654 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |